Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 15 IN DEXTROSE 3 3 AND SODIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 15 IN DEXTROSE 3 3 AND SODIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride dissociates to provide potassium ions, which are essential for maintaining intracellular osmolarity, acid-base balance, nerve impulse conduction, and muscle contraction, including myocardial function. Dextrose provides glucose for cellular energy metabolism, and sodium chloride provides sodium and chloride ions to maintain extracellular fluid volume and osmolality.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion. Dose based on serum potassium, rate not exceeding 10 mEq/hour (0.15% KCl = 20 mEq/L; typical rate 100-200 mL/hour).
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium has no true elimination half-life as it is homeostatically regulated. The terminal half-life of infused potassium is approximately 1-1.5 hours, reflecting rapid cellular uptake and renal excretion. The half-life of dextrose is minutes (insulin-dependent uptake).
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal excretion of potassium and chloride is the primary route of elimination. Potassium is almost entirely excreted by the kidneys (90-95%), with a small amount lost in feces (5-10%) and negligible biliary excretion. Dextrose and sodium are fully metabolized or excreted renally.
Category C
Category A/B
Electrolyte
Electrolyte